Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
weight-loss and diet control industry
weight-loss and diet control industry
Page 7 of 10
Health
Weight-loss drugs like Ozempic and Wegovy come with potentially serious side effects, study finds
By
Madison Muller
and
Bloomberg
October 5, 2023
Lifestyle
Weight-loss-aiding drugs Ozempic and Wegovy are dampening food sales, top Walmart exec says
By
Chloe Taylor
October 5, 2023
Health
Weight-loss drugs like Ozempic and Wegovy may be risky for older people because they melt away all-important muscles, experts say
By
Madison Muller
and
Bloomberg
September 27, 2023
Health
Weight-loss drugs like Ozempic are in such huge demand that spending on them will hit $100 billion by 2035, analyst says
By
Angel Adegbesan
and
Bloomberg
September 22, 2023
Tech
TikTok’s hidden ‘Ozempic economy,’ where weight-loss influencers trade referrals for drug discounts and cash
By
Alexandra Sternlicht
September 19, 2023
Health
Some weight loss pills used as alternatives to Ozempic and Wegovy contain toxic ingredients that are ‘potentially life-threatening’
By
Madison Muller
and
Bloomberg
September 14, 2023
Retail
Wegovy maker Novo Nordisk leapfrogs LVMH to become Europe’s most valuable company after it takes its ‘miracle’ weight loss drug to the U.K.
By
Prarthana Prakash
September 5, 2023
Health
Weight loss drugs are such big sellers now that Ozempic’s maker has overtaken LVMH as Europe’s most valuable company
By
Jonas Ekblom
,
Marthe Fourcade
and
Bloomberg
September 1, 2023
Health
Blockbuster weight loss drugs Ozempic and Wegovy cost Americans up to 10 times more than what other countries pay, research shows
By
Christiaan Hetzner
August 18, 2023
Health
A pharma company helping Elon Musk shed weight is now worth more than the entire economy of Denmark
By
Prarthana Prakash
August 11, 2023
Health
Weight-loss stocks soar up to 15% after obesity-drug study shows an added benefit that may be a ‘huge win’ for future sales
By
Angel Adegbesan
,
Jameelah Robinson
and
Bloomberg
August 8, 2023
Health
Popular weight-loss injectable Wegovy cuts risk of heart attack and stroke by 20%, company says
By
Erin Prater
August 8, 2023
Newsletters
WeightWatchers CEO says the Ozempic era signals ‘the end of diet culture.’ Could we be so lucky?
By
Maria Aspan
and
Joey Abrams
July 24, 2023
Features
The end of dieting: WeightWatchers and Noom are now pushing Ozempic-like miracle drugs over willpower
By
Maria Aspan
July 24, 2023
Health
Yet another weight loss drug is now hard to get as high demand creates major shortages
By
Emma Court
,
Madison Muller
and
Bloomberg
July 19, 2023
Most Popular
Economy
‘Sell America’: Investors dump U.S. assets in fear of the end of Fed independence
By
Jim Edwards
AI
This CEO laid off nearly 80% of his staff because they refused to adopt AI fast enough. 2 years later, he says he'd do...
By
Nick Lichtenberg
Economy
A Supreme Court ruling that strikes down Trump's tariffs would be the fastest way to revive the stalling job market,...
By
Jason Ma